Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Rockville, Maryland 20852


Purpose:

The Diabetes Prevention Program is a nationwide clinical study to answer the question: Can Type 2 diabetes (also called noninsulin-dependent or adult-onset diabetes) be prevented or delayed? The study has recruited 3819 volunteers, who are at high risk of developing diabetes, at twenty-five medical centers in the United States. It is sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health, and other Institute and corporate sponsors. Researchers will evaluate the efficacy of a lifestyle intervention and a pharmacological intervention in preventing or delaying Type 2 diabetes in persons with IGT, impaired glucose tolerance. Each person in the study will be followed for 3 to 6 years.


Criteria:

Inclusion Criteria: - Impaired glucose tolerance (FPG 95-125 mg/dL and 2hr PG 140-199 mg/dL) - BMI >= 24 kg/m2 Exclusion Criteria: - Underlying disease likely to limit life span and/or increase risk of interventions - Conditions or behaviors likely to effect conduct of the DPP - Diabetes or disordered glucose metabolism - Suboptimally treated Thyroid disease - Fasting triglyceride level < 600 mg/dl - Exclusions related to medications


NCT ID:

NCT00004992


Primary Contact:

Principal Investigator
Sarah Fowler, PhD


Backup Contact:

N/A


Location Contact:

Rockville, Maryland 20852
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: September 22, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.